The role of ICAM-1 in RA is supported by lower disease activity in a CIA model in ICAM-1-deficient mice and by clinical studies that showed beneficial effects of a blocking anti-ICAM-1 mAb in early RA (104, 105). This evidence concerns the gene ICAM1 and rheumatoid arthritis.